Search Results

There are 8262000 results for: content related to: Timing of treatment initiation in Parkinson's disease: A need for reappraisal?

  1. Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study

    Annals of Neurology

    Volume 54, Issue 1, July 2003, Pages: 93–101, Alan L. Whone, Ray L. Watts, A. Jon Stoessl, Margaret Davis, Sven Reske, Claude Nahmias, Anthony E. Lang, Olivier Rascol, Maria J. Ribeiro, Philippe Remy, Werner H. Poewe, Robert A. Hauser and David J. Brooks

    Version of Record online : 14 MAY 2003, DOI: 10.1002/ana.10609

  2. You have free access to this content
    Endogenously released DOPA is a causal factor for glutamate release and resultant delayed neuronal cell death by transient ischemia in rat striata

    Journal of Neurochemistry

    Volume 76, Issue 3, February 2001, Pages: 815–824, Nobuya Furukawa, Nobutaka Arai, Yoshio Goshima, Takeaki Miyamae, Etsuo Ohshima, Fumio Suzuki, Kiyohide Fujita and Yoshimi Misu

    Version of Record online : 7 JUL 2008, DOI: 10.1046/j.1471-4159.2001.00068.x

  3. Nicotine reduces levodopa-induced dyskinesias in lesioned monkeys

    Annals of Neurology

    Volume 62, Issue 6, December 2007, Pages: 588–596, Maryka Quik, Heather Cox, Neeraja Parameswaran, Kathryn O'Leary, J. William Langston and Donato Di Monte

    Version of Record online : 24 OCT 2007, DOI: 10.1002/ana.21203

  4. Development of dyskinesias in a 5-year trial of ropinirole and L-dopa

    Movement Disorders

    Volume 21, Issue 11, November 2006, Pages: 1844–1850, Olivier Rascol, David J. Brooks, Amos D. Korczyn, Peter P. De Deyn, Carl E. Clarke, Anthony E. Lang and Mona Abdalla

    Version of Record online : 6 SEP 2006, DOI: 10.1002/mds.20988

  5. d-DOPA IS UNIDIRECTIONALLY CONVERTED TO l-DOPA BY d-AMINO ACID OXIDASE, FOLLOWED BY DOPA TRANSAMINASE

    Clinical and Experimental Pharmacology and Physiology

    Volume 33, Issue 11, November 2006, Pages: 1042–1046, Mei Wu, Xiang-Jun Zhou, Ryuichi Konno and Yong-Xiang Wang

    Version of Record online : 16 OCT 2006, DOI: 10.1111/j.1440-1681.2006.04484.x

  6. Dopamine-dependent motor learning: Insight into levodopa's long-duration response

    Annals of Neurology

    Volume 67, Issue 5, May 2010, Pages: 639–647, Jeff A. Beeler, Zhen Fang Huang Cao, Mazen A. Kheirbek, Yunmin Ding, Jessica Koranda, Mari Murakami, Un Jung Kang and Xiaoxi Zhuang

    Version of Record online : 23 DEC 2009, DOI: 10.1002/ana.21947

  7. Cyclic AMP responsive element binding protein phosphorylation and persistent expression of levodopa-induced response alterations in unilateral nigrostriatal 6-OHDA lesioned rats

    Journal of Neuroscience Research

    Volume 72, Issue 6, 15 June 2003, Pages: 768–780, Justin D. Oh, Karnon Chartisathian, Syed M. Ahmed and Thomas N. Chase

    Version of Record online : 25 APR 2003, DOI: 10.1002/jnr.10629

  8. Multiple small doses of levodopa plus entacapone produce continuous dopaminergic stimulation and reduce dyskinesia induction in MPTP-treated drug-naïve primates

    Movement Disorders

    Volume 20, Issue 3, March 2005, Pages: 306–314, Lance A. Smith, Michael J. Jackson, Ghassan Al-Barghouthy, Sarah Rose, Mikko Kuoppamaki, Warren Olanow and Peter Jenner

    Version of Record online : 15 OCT 2004, DOI: 10.1002/mds.20317

  9. Effect of pulsatile administration of levodopa on dyskinesia induction in drug-naïve MPTP-treated common marmosets: Effect of dose, frequency of administration, and brain exposure

    Movement Disorders

    Volume 18, Issue 5, May 2003, Pages: 487–495, Lance A. Smith, Michael J. Jackson, Matthew J. Hansard, Eleni Maratos and Peter Jenner

    Version of Record online : 28 MAR 2003, DOI: 10.1002/mds.10394

  10. The dopamine transporter: Importance in Parkinson's disease

    Annals of Neurology

    Volume 55, Issue 6, June 2004, Pages: 766–773, John G. Nutt, Julie H. Carter and Gary J. Sexton

    Version of Record online : 27 MAY 2004, DOI: 10.1002/ana.20089

  11. Antiparkinsonian activity and dyskinesia risk of ropinirole and L-DOPA combination therapy in drug naive MPTP-lesioned common marmosets (Callithrix jacchus)

    Movement Disorders

    Volume 16, Issue 4, July 2001, Pages: 631–641, Eleni C. Maratos, Michael J. Jackson, Ronald K. B. Pearce and Peter Jenner

    Version of Record online : 11 JUL 2001, DOI: 10.1002/mds.1149

  12. Evolution of the response to levodopa during the first 4 years of therapy

    Annals of Neurology

    Volume 51, Issue 6, June 2002, Pages: 686–693, John G. Nutt, Julie H. Carter, Eric S. Lea and Gary J. Sexton

    Version of Record online : 21 MAY 2002, DOI: 10.1002/ana.10189

  13. Docosahexaenoic acid reduces levodopa-induced dyskinesias in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys

    Annals of Neurology

    Volume 59, Issue 2, February 2006, Pages: 282–288, Pershia Samadi, Laurent Grégoire, Claude Rouillard, Paul J. Bédard, Thérèse Di Paolo and Daniel Lévesque

    Version of Record online : 25 JAN 2006, DOI: 10.1002/ana.20738

  14. You have free access to this content
    l-DOPA and glia-conditioned medium have additive effects on tyrosine hydroxylase expression in human catecholamine-rich neuroblastoma NB69 cells

    Journal of Neurochemistry

    Volume 78, Issue 3, August 2001, Pages: 535–545, E. Rodríguez-Martín, S. Canals, M. J. Casarejos, S. de Bernardo, A. Handler and M. A. Mena

    Version of Record online : 20 DEC 2001, DOI: 10.1046/j.1471-4159.2001.00440.x

  15. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 27, Issue S1, June 2012, Pages: S1–S523,

    Version of Record online : 19 JUN 2012, DOI: 10.1002/mds.25051

  16. Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: The STRIDE-PD study

    Annals of Neurology

    Volume 68, Issue 1, July 2010, Pages: 18–27, Fabrizio Stocchi, Olivier Rascol, Karl Kieburtz, Werner Poewe, Joseph Jankovic, Eduardo Tolosa, Paulo Barone, Anthony E. Lang and C. Warren Olanow

    Version of Record online : 23 APR 2010, DOI: 10.1002/ana.22060

    Corrected by:

    Erratum: Erratum: Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: The STRIDE-PD study

    Vol. 68, Issue 3, 412–413, Version of Record online: 31 AUG 2010

  17. Cyclodextrin Host-Guest Recognition Approach for Simultaneous Quantification and Voltammetric Studies of Levodopa and Carbidopa in Pharmaceutical Products

    Electroanalysis

    Volume 23, Issue 12, December 2011, Pages: 2878–2887, Abdolkarim Abbaspour, Elham Dehghani and Abolhassan Noori

    Version of Record online : 24 NOV 2011, DOI: 10.1002/elan.201100327

  18. The history of dopamine and levodopa in the treatment of Parkinson's disease

    Movement Disorders

    Volume 23, Issue S3, 2008, Pages: S497–S508, Stanley Fahn

    Version of Record online : 9 SEP 2008, DOI: 10.1002/mds.22028

  19. Drug selection and timing of initiation of treatment in early Parkinson's disease

    Annals of Neurology

    Volume 64, Issue S2, December 2008, Pages: S47–S55, Anthony H. V. Schapira and C. Warren Olanow

    Version of Record online : 6 JAN 2009, DOI: 10.1002/ana.21460

  20. Homocysteine levels after acute levodopa intake in patients with Parkinson's disease

    Movement Disorders

    Volume 24, Issue 9, 15 July 2009, Pages: 1339–1343, Thomas Müller and Wilfried Kuhn

    Version of Record online : 7 MAY 2009, DOI: 10.1002/mds.22607